Navigation Links
Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
Date:9/10/2013

an organization that is known for its deep commitment to science and to bringing life changing medicines to patients," said Robert Landry.  "I am excited about this opportunity and look forward to working with the talented Regeneron management team."

Prior to serving as Senior Vice President and Treasurer of Pfizer, Mr. Landry held a variety of U.S. and international financial and general management positions at Wyeth and Pfizer including Senior Vice President – Finance, Pfizer's Diversified Businesses, Treasurer of Wyeth, Director of Sales and Marketing and Chief Financial Officer for Wyeth Pharmaceuticals' Australian and New Zealand affiliates, and various other assignments in both the pharmaceuticals business and the parent company.  Mr. Landry joined Wyeth after spending two years as an auditor with PricewaterhouseCoopers LLP.  He holds a B.B.A in Accounting from the University of Notre Dame.

About Regeneron Pharmaceuticals
Regeneron is a leading science-based biopharmaceutical company based in Tarrytown, New York that discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.  Regeneron markets medicines for eye diseases, colorectal cancer, and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, allergic asthma, and atopic dermatitis.  For additional information about the company, please visit www.regeneron.com.Contact Information:Manisha Narasimhan, Ph.D.Peter DworkinInvestor RelationsCorporate Communications914.847.512914.847.764manisha.narasimhan@regeneron.competer.dworkin@regeneron.com


'/>"/>
SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regenerons Eylea Now Captures One-Quarter Of Wet AMD Patient Share, Surpassing Share Of Roche/Genentechs Lucentis
2. Quarterly Financial Results and Development Program Updates - Research Report on Regeneron, DaVita, Celldex, Isis, and VIVUS
3. Regeneron Reports Second Quarter 2013 Financial and Operating Results
4. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
5. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
6. Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
7. Regeneron Acquires Full Rights to Two Novel Ophthalmology Development Programs
8. Regeneron to Report First Quarter 2013 Financial and Operating Results and Host Conference Call and Webcast on May 3, 2013
9. Regeneron Pharmaceuticals Announces Expansion in New Yorks Hudson Valley
10. Sanofi and Regeneron Report Positive Proof-of-Concept Data for Dupilumab, an IL-4R alpha Antibody, in Atopic Dermatitis
11. Zacks Bull and Bear of the Day Highlights: Fortune Brands Home & Security, Wal-Mart Stores, Regeneron Pharmaceuticals, Bayer and Array Biopharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Kinex Pharmaceuticals announced the receipt ... Company,s KX2-391 Ointment for the commencement of a Phase ... Company,s third IND to be allowed by the US ... is a synthetic, orally active and highly selective inhibitor ... promotes the induction of p53, G2/M arrest of proliferating ...
(Date:7/24/2014)... , July 24, 2014 Research ... "Machine Health Monitoring Market by Product, Component, Application and ... report to their offering. ... market is expected to witness a moderate growth as ... have almost reached the saturation levels. The ...
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- "North America ... key market data on the North America Orthopedic Braces ... of US dollars, and volume (in units) and average ... , Knee Braces and Supports , Ankle ... , Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... the College on Problems of Drug Dependence Annual Meeting , ... Pharmaceuticals, Inc. (NYSE: KG ) today announced that ... and EMBEDA(TM) (ALO-01), two novel opioid analgesic formulations ... the College on Problems of Drug Dependence. King is ...
... shows personalized chemotherapy can improve cure rate and avoid ... , , MEMPHIS, Tenn., June 24 ... successfully treated using a carefully personalized chemotherapy regimen without ... have found. Such radiation of the brain was once ...
Cached Medicine Technology:King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 2King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 3King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 4King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 5King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 6Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 2Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 3Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation 4
(Date:7/24/2014)... Research Triangle Park, NC (PRWEB) July 24, 2014 ... the elderly, ethnic minorities, and low-income households are ... private and public food safety net in the ... RTI International. , Under Section 743 of the ... the U.S. Department of Agriculture's Food and Nutrition ...
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... HealthDay Reporter THURSDAY, July 24, 2014 (HealthDay ... dead wrong, according to a small study that asked boys what ... boys between the ages of 14 and 16, researchers found that ... closeness and trust. Very few boasted about sexual conquests or saw ... girl. "In our culture, we have lots of assumptions about ...
(Date:7/24/2014)... By Kathleen Doheny ... -- Parents of obese children often don,t view their kids ... or inactivity, according to a new study. The children ... an obesity clinic at the Hasbro Children,s Hospital in Providence, ... or very good," said study researcher Dr. Kyung Rhee, now ...
(Date:7/24/2014)... School of Medicine researchers may have found a way ... discovered that pre-treatment of neurons with the anti-aging protein ... the toxic amyloid protein and glutamate. These findings currently ... , Alzheimer,s disease is the most frequent age-related ... people age 65 and older and more than 40 ...
Breaking Medicine News(10 mins):Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 2Health News:Report: Vulnerable Populations Disproportionately Affected by Food Security, Despite Public Programs 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 2Health News:Teenage Boys Want Intimacy, Not Just Sex, Survey Finds 3Health News:Parents of Obese Kids Often View Them as Healthy 2Health News:Parents of Obese Kids Often View Them as Healthy 3Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2
... , , STEWARTVILLE, Minn., July 30 Rochester ... third quarter ended June 30, 2009. , , The Company ... third quarter of last year. The Company also reported net loss of ... of $312,000 or $.02 per diluted share for the same period of last ...
... INDIANAPOLIS, July 30 WellPoint, Inc. (NYSE: ... for the administration of the H1N1 (swine flu) vaccine when ... administration will be covered for members whose benefit plans provide ... also continue coverage of seasonal flu vaccine administration for those ...
... , , , , ... today reported revenue for the second quarter of 2009 of $41.0 million. ... to revenue of $42.1 million and a net loss of $7.7 million, ... , Excluding amortization of purchased intangible assets, stock compensation and ...
... shows they,re at increased risk of psychological distress years ... survivors are more likely than their healthy peers to ... even a decade after treatment ends, new research shows. ... of diagnosis, unmarried, had less than a high school ...
... , Perkins challenges Planned Parenthood President to Debate ... Research Council Action President Tony Perkins today urged the House Energy ... of health care providers and ensure that Americans, tax dollars are ... Perkins also responded to attacks by Planned Parenthood and the ...
... , WASHINGTON, July 30 An estimated ... if Congress passes a House health reform bill, according to ... 2009 released this week by The Heritage ... The Lewin Group , a highly respected health ...
Cached Medicine News:Health News:Rochester Medical Reports Third Quarter Results 2Health News:Rochester Medical Reports Third Quarter Results 3Health News:Rochester Medical Reports Third Quarter Results 4Health News:Rochester Medical Reports Third Quarter Results 5Health News:Rochester Medical Reports Third Quarter Results 6Health News:Rochester Medical Reports Third Quarter Results 7Health News:Rochester Medical Reports Third Quarter Results 8Health News:Rochester Medical Reports Third Quarter Results 9Health News:Rochester Medical Reports Third Quarter Results 10Health News:Rochester Medical Reports Third Quarter Results 11Health News:WellPoint Announces Decision to Cover H1N1 Vaccine Administration 2Health News:Cepheid Reports 2009 Second Quarter Results 2Health News:Cepheid Reports 2009 Second Quarter Results 3Health News:Cepheid Reports 2009 Second Quarter Results 4Health News:Cepheid Reports 2009 Second Quarter Results 5Health News:Cepheid Reports 2009 Second Quarter Results 6Health News:Cepheid Reports 2009 Second Quarter Results 7Health News:Cepheid Reports 2009 Second Quarter Results 8Health News:Cepheid Reports 2009 Second Quarter Results 9Health News:Cepheid Reports 2009 Second Quarter Results 10Health News:Cepheid Reports 2009 Second Quarter Results 11Health News:Cepheid Reports 2009 Second Quarter Results 12Health News:Cepheid Reports 2009 Second Quarter Results 13Health News:Cepheid Reports 2009 Second Quarter Results 14Health News:Cepheid Reports 2009 Second Quarter Results 15Health News:Cepheid Reports 2009 Second Quarter Results 16Health News:Cepheid Reports 2009 Second Quarter Results 17Health News:Cepheid Reports 2009 Second Quarter Results 18Health News:Cancer Survivors Face Tough Road Long After Treatment Ends 2Health News:Cancer Survivors Face Tough Road Long After Treatment Ends 3Health News:FRC: The Truth Hurts Planned Parenthood and NARAL 2Health News:Millions of Virginians Could Lose Private Insurance, Study Shows 2
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
... The DRS 2000, a uniquely intelligent system, ... its space saving, 2-level design. Up to 27 ... to give you the flexibility to tailor your ... lab. Two start stations allow for continuous loading; ...
... latest from the leader in automatic slide ... modern approach to slide staining, ending messy ... blood smears, bone marrow and other body ... Aerospray stainer becomes a superb cytocentrifuge with ...
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Medicine Products: